<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00714454</url>
  </required_header>
  <id_info>
    <org_study_id>97269358-APS</org_study_id>
    <nct_id>NCT00714454</nct_id>
  </id_info>
  <brief_title>5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris</brief_title>
  <official_title>5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris: A Double-Blind, Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ikeno Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      12-week study to compare the efficacy and safety of a course of a twice daily treatment with
      APS in the form of a lotion to its vehicle for the treatment of acne.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>2</number_of_arms>
  <condition>Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>APS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>APS Topical Lotion</intervention_name>
    <arm_group_label>APS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Vehicle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has read, understood, and signed appropriate informed consent, photo consent,
             and HIPAA consent in their own language.

          -  Subject has visible mild to severe acne, as assessed by the investigator.

          -  Subject will be available and willing to return for follow-up visits.

          -  Subject agrees not to use any other acne treatment products during the study.

          -  Subject is otherwise healthy, non-febrile, and is not suffering from an infection
             likely to require antibiotic therapy during the study period.

          -  Subject or guardian must be able to understand the new HIPAA regulations and sign the
             HIPAA form.

          -  Subject is between the ages of 18 and 39.

          -  Subject agrees and understands that APS or its vehicle is to be applied to the subject
             twice daily for 12 weeks; no other topical or systemic medication affecting the course
             of acne and/or evaluability is to be used during the study.

          -  Subject agrees to use only the cleanser, moisturizer with sunscreen, and treatment
             provided by the study site for the duration of the study.

          -  Subject understands and agrees that he/she can not be treated with a systemic
             antibiotic for acne during the study.

          -  Subject agrees he/she will not use an acne topical treatment for two weeks prior to
             Day 0.

        Exclusion Criteria:

          -  Subject or guardian has not signed informed consent, photo consent or HIPAA form.

          -  Subject is suffering from a condition likely to require medical attention, including
             administration of oral or systemic antibiotics, oral or systemic corticosteroids, or
             any other treatment which in the opinion of the investigator could influence the
             results of the study.

          -  Subject is pregnant or lactating.

          -  Subject is suffering from an abnormal skin condition not usually associated with acne.

          -  Subject will not be available for follow-up visits.

          -  Subject has been previously enrolled in any clinical study in which treatment was
             received within the past 30 days.

          -  Subjects without comedones, papules, pustules, or nodules.

          -  Subject has a history of hypersensitivity to any other ingredients of the study
             lotion.

          -  Subject has a history of anaphylaxis.

          -  Subject is not able to avoid excessive sun exposure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Woolery-Lloyd, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami Cosmetic Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2008</study_first_submitted>
  <study_first_submitted_qc>July 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2008</study_first_posted>
  <last_update_submitted>July 11, 2008</last_update_submitted>
  <last_update_submitted_qc>July 11, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbate-2-phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

